Tag: Atrial Fibrillation
Apixaban Tx Cost in A-Fib Meets U.S. Norms for Reasonable Value
Incremental cost of achieving longer life expectancy within accepted U.S. norm ($53,925/QALY)
ACC: Antithrombotic Benefit Found Lacking in Low-Risk A-Fib
Researchers found low-risk patients fared better without any antithrombotic therapy
Many A-Fib Patients Not Getting Appropriate Anticoagulation Rx
More than 80 percent of ischemic stroke patients weren't getting adequate anticoagulation
ACC: Zika Linked to Negative Cardiovascular Effects in Adults
Eight Venezuelan patients developed arrhythmias, heart failure after infection
NOACs Have Been Widely Adopted Into Practice
Non-vitamin K antagonist oral anticoagulants prescribed more often than vitamin K antagonists
Hospitalizations for Atrial Fibrillation on the Rise
But patients with the condition also more likely to survive, researchers say
TGF-β1 Linked to Recurrent A-Fib After Catheter Ablation
Patients with paroxysmal atrial fibrillation have highest levels of transforming growth factor-β1
Diabetes Requiring Insulin Tied to Increased Stroke Risk in A-Fib
Patients requiring insulin, but not those without diabetes or without insulin, have increased risk
Satisfactory Overall Success Rate for Catheter Ablation in A-Fib
Study also finds insufficient guideline adherence to antithrombotic Rx after ablation
Lower Inpatient Costs for Dabigatran, Rivaroxaban in A-Fib
Lower inpatient costs with dabigatran, rivaroxaban versus warfarin for newly diagnosed atrial fibrillation
